Superficial Basal Cell Carcinoma — Trials

Superficial Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

18 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 40%
Top sponsor: Biofrontera Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05157763	A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma	recruiting	Phase 1 / Phase 2	32	MediWound LtdINDUSTRY	1	Dec 15, 2021	clinicaltrials

Data updated 22 days agoSource updated Dec 15, 2021source: clinicaltrials